Table 1.
Characteristics and baseline outcome of the subjects at baseline
| PG (n = 15) |
SG (n = 15) |
P-value | |
|---|---|---|---|
| Age (yr) | 50.3 ± 5.6 (39-58) | 49.3 ± 7.7 (38-59) | 0.70 |
| Height (cm) | 161.4 ± 5.4 (154-171) | 159.5 ± 7.5 (150-173) | 0.45 |
| BW (kg) | 66.9 ± 8.7 (53.9-78.5) | 68.1 ± 12.1 (57.5-92.7) | 0.71 |
| BMI (kg/m2) | 25.6 ± 2.4 (21.8-29.1) | 26.6 ± 3.2 (22.7-34.3) | 0.29 |
| %BF | 31.5 ± 4.6 (24.7-37.6) | 31.6 ± 3.4 (26.7-37.2) | 0.92 |
| FM (kg) | 21.3 ± 5.1 (13.3-28.5) | 21.7 ± 5.2 (15.9-32.7) | 0.81 |
| FFM (kg) | 45.6 ± 4.7 (37.6-52.9) | 46.4 ± 7.6 (37.7-60.9) | 0.69 |
| W (cm) | 84.6 ± 6.9 (72-94) | 85.8 ± 9.6 (74.5-107) | 0.66 |
| H (cm) | 95.3 ± 4.9 (86-101.5) | 96.9 ± 5.4 (88-108) | 0.35 |
| W/H ratio | 0.89 ± 0.1 (0.77-0.94) | 0.88 ± 0.1 (0.79-1.02) | 0.75 |
| MDA (μmol/L) | 1.9 ± 0.62 (0.86-2.78) | 1.8 ± 0.6 (1.19-2.81) | 0.67 |
| Vitamin E (μmol/L) |
26.5 ± 5.5 (17.2-34.4) | 29.4 ± 6.0 (19.1-45.8) | 0.18 |
| SBP (mmHg) | 130.4 ± 4.8 (127-138) | 129.3 ± 6.8 (121-137) | 0.43 |
| DBP (mmHg) | 80.6 ± 7.7 (72-99) | 77.0 ± 7.4 (65-87) | 0.63 |
| MAP (mmHg) | 97.2 ± 4.7 (90.3-108.7) | 94.4 ± 6.1 (84.7-103.7) | 0.51 |
| HR (/min) | 66.8 ± 7.4 (59-85) | 68.7 ± 9.1 (53-93) | 0.61 |
Values are expressed as means ± SD (minimum-maximum).
PG, placebo group; SG, black sesame meal group; BW, body weight; BMI, body mass index; %BF, percentage of body fat; FM, fat mass; FFM, fat-free mass; W, waist circumference; H, hip circumference; W/H ratio, waist and hip circumference ratio; MDA, malondialdehyde; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; HR, heart rate